Biomimetic Approaches for Bone Tissue Engineering

Tissue Engineering - Part B: Reviews

Volumn 23, Issue 5, 2017, Pages 480-493

  Ng, Johnathan ^a   Spiller, Kara ^b   Bernhard, Jonathan ^a   Vunjak Novakovic, Gordana ^a,c  

^a Department of Earth and Environmental Sciences   (United States)

^b DREXEL UNIVERSITY   (United States)

^c NONE   (United States)

Author keywords

biomimetics; bone; tissue engineering

Indexed keywords

BIOMIMETICS; BONE; CELL ENGINEERING; REPAIR; SCAFFOLDS (BIOLOGY); TISSUE ENGINEERING;

AUTOLOGOUS CELL; BIOMIMETIC APPROACHES; BIOREACTOR CULTURES; BONE SCAFFOLDS; BONE TISSUE ENGINEERING; ENDOCHONDRAL OSSIFICATION; GOLD STANDARDS; VASCULARIZATION;

TISSUE;

ANGIOGENIC FACTOR; CALCIUM PHOSPHATE; GAMMA INTERFERON; HYALURONIC ACID; HYDROXYAPATITE; PLATELET DERIVED GROWTH FACTOR; POLYETHYLENE TEREPHTHALATE; VASCULOTROPIN; ZIRCONIUM OXIDE;

ADIPOSE DERIVED STEM CELL; BIOMIMETICS; BONE MARROW DERIVED MESENCHYMAL STEM CELL; BONE REGENERATION; BONE REMODELING; BONE TISSUE; CELL DIFFERENTIATION; CELL PROLIFERATION; ENCHONDRAL OSSIFICATION; EXTRACELLULAR MATRIX; GRAFT SURVIVAL; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MACROPHAGE; NANOFABRICATION; PHENOTYPIC PLASTICITY; PRIORITY JOURNAL; REVIEW; THREE DIMENSIONAL PRINTING; TISSUE DIFFERENTIATION; TISSUE ENGINEERING; ANGIOGENESIS; ANIMAL; BIOREACTOR; BONE; CHEMISTRY; PHYSIOLOGY; PROCEDURES; TISSUE SCAFFOLD;

ANIMALS; BIOMIMETICS; BIOREACTORS; BONE AND BONES; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 85028926011     PISSN: 19373368     EISSN: 19373376     Source Type: Journal    
DOI: 10.1089/ten.teb.2016.0289     Document Type: Review

References (166)

1. Cheung, C. The future of bone healing. Clin Podiatr Med Surg 22, 631, 2005.
2. Betz, R.R. Limitations of autograft and allograft: new synthetic solutions. Orthopedics 25, s561, 2002.
3. Fuchs, S., Ghanaati, S., Orth, C., Barbeck, M., Kolbe, M., Hofmann, A., Eblenkamp, M., Gomes, M., Reis, R.L., and Kirkpatrick, C.J. Contribution of outgrowth endothelial cells from human peripheral blood on in vivo vascularization of bone tissue engineered constructs based on starch polycaprolactone scaffolds. Biomaterials 30, 526, 2009.
4. Santos, M.I., Tuzlakoglu, K., Fuchs, S., Gomes, M.E., Peters, K., Unger, R.E., Piskin, E., Reis, R.L., and Kirkpatrick, C.J. Endothelial cell colonization and angiogenic potential of combined nano-and micro-fibrous scaffolds for bone tissue engineering. Biomaterials 29, 4306, 2008.
5. Meinel, L., Karageorgiou, V., Hofmann, S., Fajardo, R., Snyder, B., Li, C., Zichner, L., Langer, R., Vunjak-Novakovic, G., and Kaplan, D.L. Engineering bone-like tissue in vitro using human bone marrow stem cells and silk scaffolds. J Biomed Mater Res A 71, 25, 2004.
6. Hofmann, S., Hagenmuller, H., Koch, A.M., Muller, R., Vunjak-Novakovic, G., Kaplan, D.L., Merkle, H.P., and Meinel, L. Control of in vitro tissue-engineered bone-like structures using human mesenchymal stem cells and porous silk scaffolds. Biomaterials 28, 1152, 2007.
7. Burg, K.J.L., Porter, S., and Kellam, J.F. Biomaterial developments for bone tissue engineering. Biomaterials 21, 2347, 2000.
8. Rezwan, K., Chen, Q.Z., Blaker, J.J., and Boccaccini, A.R. Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering. Biomaterials 27, 3413, 2006.
9. Zhou, J., Lin, H., Fang, T., Li, X., Dai, W., Uemura, T., and Dong, J. The repair of large segmental bone defects in the rabbit with vascularized tissue engineered bone. Biomaterials 31, 1171, 2010.
10. Grayson, W.L., Bhumiratana, S., Cannizzaro, C., Chao, P.H., Lennon, D.P., Caplan, A.I., and Vunjak-Novakovic, G. Effects of initial seeding density and fluid perfusion rate on formation of tissue-engineered bone. Tissue Eng Part A 14, 1809, 2008.
11. Urist, M.R. Bone: formation by autoinduction. Science 150, 893, 1965.
12. Hollister, S.J. Porous scaffold design for tissue engineering. Nat Mater 4, 518, 2005.
13. Woodruff, M.A, and Hutmacher, D.W. The return of a forgotten polymer-Polycaprolactone in the 21st century. Prog Polym Sci 35, 1217, 2010.
14. Johnson, A.J.W, and Herschler, B.A. A review of the mechanical behavior of CaP and CaP/polymer composites for applications in bone replacement and repair. Acta Biomater 7, 16, 2011.
15. Roohani-Esfahani, S.I., Nouri-Khorasani, S., Lu, Z.F., Appleyard, R.C., and Zreiqat, H. Effects of bioactive glass nanoparticles on the mechanical and biological behavior of composite coated scaffolds. Acta Biomater 7, 1307, 2011.
16. Roohani-Esfahani, S.I., Nouri-Khorasani, S., Lu, Z., Appleyard, R., and Zreiqat, H. The influence hydroxyapatite nanoparticle shape and size on the properties of biphasic calcium phosphate scaffolds coated with hydroxyapatite-PCL composites. Biomaterials 31, 5498, 2010.
17. Kane, R.J., Weiss-Bilka, H.E., Meagher, M.J., Liu, Y.X., Gargac, J.A., Niebur, G.L., Wagner, D.R., and Roeder, R.K. Hydroxyapatite reinforced collagen scaffolds with improved architecture and mechanical properties. Acta Biomater 17, 16, 2015.
18. Seol, Y.J., Park, D.Y., Park, J.Y., Kim, S.W., Park, S.J., and Cho, D.W. A new method of fabricating robust freeform 3D ceramic scaffolds for bone tissue regeneration. Biotechnol Bioeng 110, 1444, 2013.
19. Petite, H., Viateau, V., Bensaid, W., Meunier, A., de Pollak, C., Bourguignon, M., Oudina, K., Sedel, L., and Guillemin, G. Tissue-engineered bone regeneration. Nat Biotechnol 18, 959, 2000.
20. Loh, Q.L, and Choong, C. Three-dimensional scaffolds for tissue engineering applications: role of porosity and pore size. Tissue Eng Part B Rev 19, 485, 2013.
21. Felzmann, R., Gruber, S., Mitteramskogler, G., Tesavibul, P., Boccaccini, A.R., Liska, R., and Stampfl, J. Lithography-based additive manufacturing of cellular ceramic structures. Adv Eng Mater 14, 1052, 2012.
22. Jakus, A.E., Rutz, A.L., Jordan, S.W., Kannan, A., Mitchell, S.M., Yun, C., Koube, K.D., Yoo, S.C., Whiteley, H.E., Richter, C.P., Galiano, R.D., Hsu, W.K., Stock, S.R., Hsu, E.L., and Shah, R.N. Hyperelastic ''bone'': a highly versatile, growth factor-free, osteoregenerative, scalable, and surgically friendly biomaterial. Sci Transl Med 8, 358ra127, 2016.
23. Kang, H.W., Lee, S.J., Ko, I.K., Kengla, C., Yoo, J.J., and Atala, A. A 3D bioprinting system to produce humanscale tissue constructs with structural integrity. Nat Biotechnol 34, 312, 2016.
24. Urist, M.R., Delange, R.J., and Finerman, G.A.M. Bone cell differentiation and growth factors. Science 220, 680, 1983.
25. Wozney, J.M., Rosen, V., Celeste, A.J., Mitsock, L.M., Whitters, M.J., Kriz, R.W., Hewick, R.M., and Wang, E.A. Novel regulators of bone formation: molecular clones and activities. Science 242, 1528, 1988.
26. Sampath, T.K., Muthukumaran, N., and Reddi, A.H. Isolation of osteogenin, an extracellular matrix-associated, bone-inductive protein, by heparin affinity chromatography. Proc Natl Acad Sci USA 84, 7109, 1987.
27. Mauney, J.R., Jaquiery, C., Volloch, V., Herberer, M., Martin, I., and Kaplan, D.L. In vitro and in vivo evaluation of differentially demineralized cancellous bone scaffolds combined with human bone marrow stromal cells for tissue engineering. Biomaterials 26, 3173, 2005.
28. Davy, D.T. Biomechanical issues in bone transplantation. Orthop Clin North Am 30, 553, 1999.
29. Song, J.J, and Ott, H.C. Organ engineering based on decellularized matrix scaffolds. Trends Mol Med 17, 424, 2011.
30. Bhumiratana, S, and Vunjak-Novakovic, G. Concise review: personalized human bone grafts for reconstructing head and face. Stem Cells Transl Med 1, 64, 2012.
31. Mailhot, J.M, and Borke, J.L. An isolation and in vitro culturing method for human intraoral bone cells derived from dental implant preparation sites. Clin Oral Implants Res 9, 43, 1998.
32. Voegele, T.J., Voegele-Kadletz, M., Esposito, V., Macfelda, K., Oberndorfer, U., Vecsei, V., and Schabus, R. The effect of different isolation techniques on human osteoblastlike cell growth. Anticancer Res 20, 3575, 2000.
33. Hutmacher, D.W, and Sittinger, M. Periosteal cells in bone tissue engineering. Tissue Eng 9, S45, 2003.
34. Pittenger, M.F., Mackay, A.M., Beck, S.C., Jaiswal, R.K., Douglas, R.,Mosca, J.D., Moorman, M.A., Simonetti,D.W., Craig, S., andMarshak, D.R. Multilineage potential of adult human mesenchymal stem cells. Science 284, 143, 1999.
35. Friedenstein, A.J., Chailakhyan, R.K., and Gerasimov, U.V. Bone marrow osteogenic stem cells: in vitro cultivation and transplantation in diffusion chambers. Cell Tissue Kinetics 20, 263, 1987.
36. Datta, N., Pham, Q.P., Sharma, U., Sikavitsas, V.I., Jansen, J.A., and Mikos, A.G. In vitro generated extracellular matrix and fluid shear stress synergistically enhance 3D osteoblastic differentiation. Proc Natl Acad Sci U S A 103, 2488, 2006.
37. Zuk, P.A., Zhu, M., Mizuno, H., Huang, J., Futrell, J.W., Katz, A.J., Benhaim, P., Lorenz, H.P., and Hedrick, M.H. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7, 211, 2001.
38. Cao, Y., Sun, Z., Liao, L., Meng, Y., Han, Q., and Zhao, R.C. Human adipose tissue-derived stem cells differentiate into endothelial cells in vitro and improve postnatal neovascularization in vivo. Biochem Biophys Res Commun 332, 370, 2005.
39. Frohlich, M., Grayson, W.L., Marolt, D., Gimble, J.M., Kregar-Velikonja, N., and Vunjak-Novakovic, G. Bone grafts engineered from human adipose-derived stem cells in perfusion bioreactor culture. Tissue Eng Part A 16, 179, 2010.
40. Correia, C., Bhumiratana, S., Yan, L.P., Oliveira, A.L., Gimble, J.M., Rockwood, D., Kaplan, D.L., Sousa, R.A., Reis, R.L., and Vunjak-Novakovic, G. Development of silkbased scaffolds for tissue engineering of bone from human adipose-derived stem cells. Acta Biomater 8, 2483, 2012.
41. Diederichs, S., Roker, S., Marten, D., Peterbauer, A., Scheper, T., van Griensven, M., and Kasper, C. Dynamic cultivation of human mesenchymal stem cells in a rotating bed bioreactor system based on the Z (R) RP platform. Biotechnol Progr 25, 1762, 2009.
42. Yasuda, K., Inoue, S., and Tabata, Y. Influence of culture method on the proliferation and osteogenic differentiation of human adipo-stromal cells in nonwoven fabrics. Tissue Eng 10, 1587, 2004.
43. Wang, T.W., Wu, H.C., Wang, H.Y., Lin, F.H., and Sun, J.S. Regulation of adult human mesenchymal stem cells into osteogenic and chondrogenic lineages by different bioreactor systems. J Biomed Mater Res A 88a, 935, 2009.
44. Ben-David, D., Kizhner, T., Livne, E., and Srouji, S. A tissue-like construct of human bone marrow MSCs composite scaffold support in vivo ectopic bone formation. J Tissue Eng Regen M 4, 30, 2010.
45. Meinel, L., Karageorgiou, V., Fajardo, R., Snyder, B., Shinde-Patil, V., Zichner, L., Kaplan, D., Langer, R., and Vunjak-Novakovic, G. Bone tissue engineering using human mesenchymal stem cells: effects of scaffold material and medium flow. Ann Biomed Eng 32, 112, 2004.
46. Kim, H.J., Kim, U.J., Leisk, G.G., Bayan, C., Georgakoudi, I., and Kaplan, D.L. Bone regeneration on macroporous aqueous-derived silk 3-D scaffolds. Macromol Biosci 7, 643, 2007.
47. Teixeira, G.Q., Barrias, C.C., Lourenco, A.H., and Goncalves, R.M. A multicompartment holder for spinner flasks improves expansion and osteogenic differentiation of mesenchymal stem cells in three-dimensional scaffolds. Tissue Eng Part C Methods 20, 984, 2014.
48. Bancroft, G.N., Sikavitsas, V.I., van den Dolder, J., Sheffield, T.L., Ambrose, C.G., Jansen, J.A., and Mikos, A.G. Fluid flow increases mineralized matrix deposition in 3D perfusion culture of marrow stromal osteoblasts in a dose-dependent manner. Proc Natl Acad Sci U S A 99, 12600, 2002.
49. Bjerre, L., Bunger, C.E., Kassem, M., and Mygind, T. Flow perfusion culture of human mesenchymal stem cells on silicate-substituted tricalcium phosphate scaffolds. Biomaterials 29, 2616, 2008.
50. Grayson, W.L., Frohlich, M., Yeager, K., Bhumiratana, S., Chan,M.E., Cannizzaro, C.,Wan, L.Q., Liu, X.S., Guo, X.E., and Vunjak-Novakovic, G. Engineering anatomically shaped human bone grafts. ProcNatlAcad SciUSA107, 3299, 2010.
51. Bhumiratana, S., Bernhard, J.C., Alfi, D.M., Yeager, K., Eton, R.E., Bova, J., Shah, F., Gimble, J.M., Lopez, M.J., Eisig, S.B., and Vunjak-Novakovic, G. Tissue-engineered autologous grafts for facial bone reconstruction. Sci Transl Med 8, 343ra83, 2016.
52. Sladkova, M, and de Peppo, G. Bioreactor systems for human bone tissue engineering. Processes 2, 494, 2014.
53. Burger, E.H, and Klein-Nulend, J. Mechanotransduction in bone-role of the lacuno-canalicular network. FASEB J 13, S101, 1999.
54. Johnson, D.L., McAllister, T.N., and Frangos, J.A. Fluid flow stimulates rapid and continuous release of nitric oxide in osteoblasts. Am J Physiol 271, E205, 1996.
55. Kavlock, K.D, and Goldstein, A.S. Effect of pulse frequency on the osteogenic differentiation of mesenchymal stem cells in a pulsatile perfusion bioreactor. J Biomech Eng 133, 091005, 2011.
56. Hoey, D.A., Tormey, S., Ramcharan, S., O'Brien, F.J., and Jacobs,C.R. Primary cilia-mediatedmechanotransduction in human mesenchymal stem cells. Stem Cells 30, 2561, 2012.
57. Knippenberg, M., Helder, M.N., Doulabi, B.Z., Semeins, C.M., Wuisman, P.I., and Klein-Nulend, J. Adipose tissuederived mesenchymal stem cells acquire bone cell-like responsiveness to fluid shear stress on osteogenic stimulation. Tissue Eng 11, 1780, 2005.
58. Chen, J.C, and Jacobs, C.R. Mechanically induced osteogenic lineage commitment of stem cells. Stem Cell Res Ther 4, 107, 2013.
59. Grayson, W.L., Marolt, D., Bhumiratana, S., Froehlich, M., Guo, X.E., and Vunjak-Novakovic, G. Optimizing the Medium Perfusion Rate in Bone Tissue Engineering Bioreactors. Biotechnol Bioeng 108, 1159, 2011.
60. Kanczler, J.M, and Oreffo, R.O. Osteogenesis and angiogenesis: the potential for engineering bone. Eur Cell Mater 15, 100, 2008.
61. Brandi, M.L, and Collin-Osdoby, P. Vascular biology and the skeleton. J Bone Miner Res 21, 183, 2006.
62. Gerber, H.P., Vu, T.H., Ryan, A.M., Kowalski, J., Werb, Z., and Ferrara, N. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 5, 623, 1999.
63. Kronenberg, H.M. Developmental regulation of the growth plate. Nature 423, 332, 2003.
64. Deckers, M.M., van Bezooijen, R.L., van der Horst, G., Hoogendam, J., van Der Bent, C., Papapoulos, S.E., and Lowik, C.W. Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A. Endocrinology 143, 1545, 2002.
65. Cao, L, and Mooney, D.J. Spatiotemporal control over growth factor signaling for therapeutic neovascularization. Adv Drug Deliv Rev 59, 1340, 2007.
66. Ball, S.G., Shuttleworth, C.A., and Kielty, C.M. Plateletderived growth factor receptors regulate mesenchymal stem cell fate: implications for neovascularization. Expert Opin Biol Ther 10, 57, 2010.
67. Gerber, H.P, and Ferrara, N. Angiogenesis and bone growth. Trends Cardiovasc Med 10, 223, 2000.
68. Khosla, S., Westendorf, J.J., and Modder, U.I. Concise review: insights from normal bone remodeling and stem cellbased therapies for bone repair. Stem Cells 28, 2124, 2010.
69. Schindeler, A., McDonald, M.M., Bokko, P., and Little, D.G. Bone remodeling during fracture repair: the cellular picture. Semin Cell Dev Biol 19, 459, 2008.
70. Mountziaris, P.M, and Mikos, A.G. Modulation of the inflammatory response for enhanced bone tissue regeneration. Tissue Eng Part B Rev 14, 179, 2008.
71. Andersen, T.L., Sondergaard, T.E., Skorzynska, K.E., Dagnaes-Hansen, F., Plesner, T.L., Hauge, E.M., Plesner, T., and Delaisse, J.M. A physical mechanism for coupling bone resorption and formation in adult human bone. Am J Pathol 174, 239, 2009.
72. Lange, R.H., Bach, A.W., Hansen, S.T., Jr., and Johansen, K.H. Open tibial fractures with associated vascular injuries: prognosis for limb salvage. J Trauma 25, 203, 1985.
73. Uhrig, B.A., Boerckel, J.D.,Willett, N.J., Li,M.T., Huebsch, N., and Guldberg, R.E. Recovery from hind limb ischemia enhances rhBMP-2-mediated segmental bone defect repair in a rat composite injury model. Bone 55, 410, 2013.
74. Kusumbe, A.P., Ramasamy, S.K., and Adams, R.H. Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone. Nature 507, 323, 2014.
75. Ramasamy, S.K., Kusumbe, A.P., Wang, L., and Adams, R.H. Endothelial Notch activity promotes angiogenesis and osteogenesis in bone. Nature 507, 376, 2014.
76. Santos, M.I., Unger, R.E., Sousa, R.A., Reis, R.L., and Kirkpatrick, C.J. Crosstalk between osteoblasts and endothelial cells co-cultured on a polycaprolactone-starch scaffold and the in vitro development of vascularization. Biomaterials 30, 4407, 2009.
77. Rouwkema, J., Westerweel, P.E., de Boer, J., Verhaar, M.C., and van Blitterswijk, C.A. The use of endothelial progenitor cells for prevascularized bone tissue engineering. Tissue Eng Part A 15, 2015, 2009.
78. Rouwkema, J., de Boer, J., and Van Blitterswijk, C.A. Endothelial cells assemble into a 3-dimensional prevascular network in a bone tissue engineering construct. Tissue Eng 12, 2685, 2006.
79. Yu, H., VandeVord, P.J., Gong, W., Wu, B., Song, Z., Matthew, H.W., Wooley, P.H., and Yang, S. Promotion of osteogenesis in tissue-engineered bone by pre-seeding endothelial progenitor cells-derived endothelial cells. J Orthop Res 26, 1147, 2008.
80. Kneser, U., Schaefer, D.J., Polykandriotis, E., and Horch, R.E. Tissue engineering of bone: the reconstructive surgeon's point of view. J Cell Mol Med 10, 7, 2006.
81. Kawamura, K., Yajima, H., Ohgushi, H., Tomita, Y., Kobata, Y., Shigematsu, K., and Takakura, Y. Experimental study of vascularized tissue-engineered bone grafts. Plast Reconstr Surg 117, 1471, 2006.
82. Wang, L., Fan, H., Zhang, Z.-Y., Lou, A.-J., Pei, G.-X., Jiang, S., Mu, T.-W., Qin, J.-J., Chen, S.-Y., and Jin, D. Osteogenesis and angiogenesis of tissue-engineered bone constructed by prevascularized beta-tricalcium phosphate scaffold and mesenchymal stem cells. Biomaterials 31, 9452, 2010.
83. Tremblay, P.L., Hudon, V., Berthod, F., Germain, L., and Auger, F.A. Inosculation of tissue-engineered capillaries with the host's vasculature in a reconstructed skin transplanted on mice. Am J Transplant 5, 1002, 2005.
84. Levenberg, S., Rouwkema, J., Macdonald, M., Garfein, E.S., Kohane, D.S., Darland, D.C., Marini, R., van Blitterswijk, C.A., Mulligan, R.C., D'Amore, P.A., and Langer, R. Engineering vascularized skeletal muscle tissue. Nat Biotechnol 23, 879, 2005.
85. Tsigkou, O., Pomerantseva, I., Spencer, J.A., Redondo, P.A., Hart, A.R., O'Doherty, E., Lin, Y., Friedrich, C.C., Daheron, L., Lin, C.P., Sundback, C.A., Vacanti, J.P., and Neville, C. Engineered vascularized bone grafts. Proc Natl Acad Sci USA 107, 3311, 2010.
86. Rivron, N.C., Raiss, C.C., Liu, J., Nandakumar, A., Sticht, C., Gretz, N., Truckenmuller, R., Rouwkema, J., and van Blitterswijk, C.A. Sonic Hedgehog-activated engineered blood vessels enhance bone tissue formation. Proc Natl Acad Sci USA 109, 4413, 2012.
87. Spiller, K.L, and Vunjak-Novakovic, G. Clinical translation of controlled protein delivery systems for tissue engineering. Drug Deliv Transl Res 5, 101, 2013.
88. Patel, Z.S., Young, S., Tabata, Y., Jansen, J.A., Wong, M.E., and Mikos, A.G. Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model. Bone 43, 931, 2008.
89. Young, S., Patel, Z.S., Kretlow, J.D., Murphy, M.B., Mountziaris, P.M., Baggett, L.S., Ueda, H., Tabata, Y., Jansen, J.A., Wong,M., andMikos, A.G. Dose effect of dual delivery of vascular endothelial growth factor and bone morphogenetic protein-2 on bone regeneration in a rat critical-size defectmodel. Tissue Eng PartA 15, 2347, 2009.
90. De la Riva, B., Sanchez, E., Hernandez, A., Reyes, R., Tamimi, F., Lopez-Cabarcos, E., Delgado, A., and Evora, C. Local controlled release of VEGF and PDGF from a combined brushite-chitosan system enhances bone regeneration. J Control Release 143, 45, 2010.
91. Kaigler, D., Silva, E.A., and Mooney, D.J. Guided bone regeneration using injectable vascular endothelial growth factor delivery gel. J Periodontol 84, 230, 2013.
92. Shah, N.J., Hyder, M.N., Quadir, M.A., Dorval Courchesne, N.M., Seeherman, H.J., Nevins, M., Spector, M., and Hammond, P.T. Adaptive growth factor delivery from a polyelectrolyte coating promotes synergistic bone tissue repair and reconstruction. Proc Natl Acad Sci U S A 111, 12847, 2014.
93. Martino, M.M., Briquez, P.S., Guc, E., Tortelli, F., Kilarski, W.W., Metzger, S., Rice, J.J., Kuhn, G.A., Muller, R., Swartz, M.A., and Hubbell, J.A. Growth factors engineered for super-affinity to the extracellular matrix enhance tissue healing. Science 343, 885, 2014.
94. Richardson, T.P., Peters, M.C., Ennett, A.B., and Mooney, D.J. Polymeric system for dual growth factor delivery. Nat Biotechnol 19, 1029, 2001.
95. Xie, H., Cui, Z., Wang, L., Xia, Z., Hu, Y., Xian, L., Li, C., Xie, L., Crane, J., Wan, M., Zhen, G., Bian, Q., Yu, B., Chang, W., Qiu, T., Pickarski, M., Duong le, T., Windle, J.J., Luo, X., Liao, E., and Cao, X. PDGF-BB secreted by preosteoclasts induces angiogenesis during coupling with osteogenesis. Nat Med 20, 1270, 2014.
96. Hellberg,C., Ostman, A., andHeldin, C.H. PDGF and vessel maturation. Recent Results Cancer Res 180, 103, 2010.
97. Yancopoulos, G.D., Davis, S., Gale, N.W., Rudge, J.S., Wiegand, S.J., and Holash, J. Vascular-specific growth factors and blood vessel formation. Nature 407, 242, 2000.
98. Carano, R.A, and Filvaroff, E.H. Angiogenesis and bone repair. Drug Discov Today 8, 980, 2003.
99. Hausman, M.R, and Rinker, B.D. Intractable wounds and infections: the role of impaired vascularity and advanced surgical methods for treatment. Am J Surg 187, 44S, 2004.
100. Grundnes, O, and Reikeras, O. The importance of the hematoma for fracture healing in rats. Acta Orthop Scand 64, 340, 1993.
101. Park, S.H., Silva, M., Bahk, W.J., McKellop, H., and Lieberman, J.R. Effect of repeated irrigation and debridement on fracture healing in an animal model. J Orthop Res 20, 1197, 2002.
102. Glass, G.E., Chan, J.K., Freidin, A., Feldmann, M., Horwood, N.J., and Nanchahal, J. TNF-alpha promotes fracture repair by augmenting the recruitment and differentiation of muscle-derived stromal cells. Proc Natl Acad Sci U S A 108, 1585, 2011.
103. Alexander, K.A., Chang, M.K., Maylin, E.R., Kohler, T., Muller, R., Wu, A.C., Van Rooijen, N., Sweet, M.J., Hume, D.A., Raggatt, L.J., and Pettit, A.R. Osteal macrophages promote in vivo intramembranous bone healing in a mouse tibial injury model. J Bone Miner Res 26, 1517, 2011.
104. Wang, X., Yu, Y.Y., Lieu, S., Yang, F., Lang, J., Lu, C., Werb, Z., Hu, D., Miclau, T., Marcucio, R., and Colnot, C. MMP9 regulates the cellular response to inflammation after skeletal injury. Bone 52, 111, 2013.
105. Champagne, C.M., Takebe, J., Offenbacher, S., and Cooper, L.F. Macrophage cell lines produce osteoinductive signals that include bone morphogenetic protein-2. Bone 30, 26, 2002.
106. Freytes, D.O., Kang, J.W., Marcos-Campos, I., and Vunjak-Novakovic, G. Macrophages modulate the viability and growth of human mesenchymal stem cells. J Cell Biochem 114, 220, 2013.
107. Pirraco, R.P., Reis, R.L., and Marques, A.P. Effect of monocytes/macrophages on the early osteogenic differentiation of hBMSCs. J Tissue Eng Regen Med 7, 392, 2013.
108. Schmidt-Bleek, K., Schell, H., Schulz, N., Hoff, P., Perka, C., Buttgereit, F., Volk, H.D., Lienau, J., and Duda, G.N. Inflammatory phase of bone healing initiates the regenerative healing cascade. Cell Tissue Res 347, 567, 2012.
109. Reikeras, O., Shegarfi, H., Wang, J.E., and Utvag, S.E. Lipopolysaccharide impairs fracture healing: an experimental study in rats. Acta Orthop 76, 749, 2005.
110. Krishnamoorthy, L. The role of macrophages in human wound healing and their response to a tissue engineered dermal replacement in human chronic wounds [MD thesis]. Wound Healing Research Unit, University of Glasgow, Glasgow, Scotland, 2006.
111. Khallou-Laschet, J., Varthaman, A., Fornasa, G., Compain, C., Gaston, A.T., Clement, M., Dussiot, M., Levillain, O., Graff-Dubois, S., Nicoletti, A., and Caligiuri, G. Macrophage plasticity in experimental atherosclerosis. PLoS One 5, e8852, 2010.
112. Kigerl, K.A., Gensel, J.C., Ankeny, D.P., Alexander, J.K., Donnelly, D.J., and Popovich, P.G. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci 29, 13435, 2009.
113. Sakurai, E., Anand, A., Ambati, B.K., van Rooijen, N., and Ambati, J. Macrophage depletion inhibits experimental choroidal neovascularization. Invest Ophthalmol Vis Sci 44, 3578, 2003.
114. Hibino, N., Yi, T., Duncan, D.R., Rathore, A., Dean, E., Naito, Y., Dardik, A., Kyriakides, T., Madri, J., Pober, J.S., Shinoka, T., and Breuer, C.K. A critical role for macrophages in neovessel formation and the development of stenosis in tissue-engineered vascular grafts. FASEB J 25, 4253, 2011.
115. Low-Marchelli, J.M., Ardi, V.C., Vizcarra, E.A., van Rooijen, N., Quigley, J.P., and Yang, J. Twist1 induces CCL2 and recruits macrophages to promote angiogenesis. Cancer Res 73, 662, 2013.
116. Fantin, A., Vieira, J.M., Gestri, G., Denti, L., Schwarz, Q., Prykhozhij, S., Peri, F., Wilson, S.W., and Ruhrberg, C. Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction. Blood 116, 829, 2010.
117. Kubota, Y., Takubo, K., Shimizu, T., Ohno, H., Kishi, K., Shibuya, M., Saya, H., and Suda, T. M-CSF inhibition selectively targets pathological angiogenesis and lymphangiogenesis. J Exp Med 206, 1089, 2009.
118. Arendt, L.M., McCready, J., Keller, P.J., Baker, D.D., Naber, S.P., Seewaldt, V., and Kuperwasser, C. Obesity promotes breast cancer by CCL2-mediated macrophage recruitment and angiogenesis. Cancer Res 73, 6080, 2013.
119. Hisatome, T., Yasunaga, Y., Yanada, S., Tabata, Y., Ikada, Y., and Ochi, M. Neovascularization and bone regeneration by implantation of autologous bone marrow mononuclear cells. Biomaterials 26, 4550, 2005.
120. Hirose, N., Maeda, H., Yamamoto, M., Hayashi, Y., Lee, G.H., Chen, L., Radhakrishnan, G., Rao, P., and Sasaguri, S. The local injection of peritoneal macrophages induces neovascularization in rat ischemic hind limb muscles. Cell Transplant 17, 211, 2008.
121. Mosser, D.M, and Edwards, J.P. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8, 958, 2008.
122. Schlundt, C., El Khassawna, T., Serra, A., Dienelt, A., Wendler, S., Schell, H., van Rooijen, N., Radbruch, A., Lucius, R., Hartmann, S., Duda, G.N., and Schmidt-Bleek, K. Macrophages in bone fracture healing: Their essential role in endochondral ossification. Bone 2015. DOI: 10.1016/j.bone.2015.10.019.
123. Loi, F., Córdova, L.A., Zhang, R., Pajarinen, J., Lin, T.-h., Goodman, S.B., and Yao, Z. The effects of immunomodulation by macrophage subsets on osteogenesis in vitro. Stem Cell Res Ther 7, 15, 2016.
124. Mirza, R.E., Fang, M.M., Weinheimer-Haus, E.M., Ennis, W.J., and Koh, T.J. Sustained inflammasome activity in macrophages impairs wound healing in type 2 diabetic humans and mice. Diabetes 63, 1103, 2014.
125. Wu, A.C., Raggatt, L.J., Alexander, K.A., and Pettit, A.R. Unraveling macrophage contributions to bone repair. Bonekey Rep 2, 373, 2013.
126. Nassiri, S., Zakeri, I., Weingarten, M.S., and Spiller, K.L. Relative expression of pro-inflammatory and antiinflammatory genes reveals differences between healing and nonhealing human chronic diabetic foot ulcers. J Invest Dermatol 135, 1700, 2015.
127. Brown, B.N., Valentin, J.E., Stewart-Akers, A.M., McCabe, G.P., and Badylak, S.F. Macrophage phenotype and remodeling outcomes in response to biologic scaffolds with and without a cellular component. Biomaterials 30, 1482, 2009.
128. Madden, L.R., Mortisen, D.J., Sussman, E.M., Dupras, S.K., Fugate, J.A., Cuy, J.L., Hauch, K.D., Laflamme, M.A., Murry, C.E., and Ratner, B.D. Proangiogenic scaffolds as functional templates for cardiac tissue engineering. Proc Natl Acad Sci U S A 107, 15211, 2010.
129. Hamlet, S, and Ivanovski, S. Inflammatory cytokine response to titanium chemical composition and nanoscale calcium phosphate surface modification. Acta Biomater 7, 2345, 2011.
130. Rao, A.J., Gibon, E., Ma, T., Yao, Z., Smith, R.L., and Goodman, S.B. Revision joint replacement, wear particles, and macrophage polarization. Acta Biomater 8, 2815, 2012.
131. Mantovani, A., Sica, A., Sozzani, S., Allavena, P., Vecchi, A., and Locati, M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 25, 677, 2004.
132. Mantovani, A., Sozzani, S., Locati, M., Allavena, P., and Sica, A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23, 549, 2002.
133. Jetten, N., Verbruggen, S., Gijbels, M.J., Post, M.J., De Winther, M.P., and Donners, M.M. Anti-inflammatory M2, but not pro-inflammatory M1 macrophages promote angiogenesis in vivo. Angiogenesis 17, 109, 2014.
134. Zajac, E., Schweighofer, B., Kupriyanova, T.A., Juncker-Jensen, A., Minder, P., Quigley, J.P., and Deryugina, E.I. Angiogenic capacity of M1-and M2-polarized macrophages is determined by the levels of TIMP-1 complexed with their secreted proMMP-9. Blood 122, 4054, 2013.
135. Fishman, J.M., Lowdell, M.W., Urbani, L., Ansari, T., Burns, A.J., Turmaine, M., North, J., Sibbons, P., Seifalian, A.M., Wood, K.J., Birchall, M.A., and De Coppi, P. Immunomodulatory effect of a decellularized skeletal muscle scaffold in a discordant xenotransplantation model. Proc Natl Acad Sci U S A 110, 14360, 2013.
136. Willenborg, S., Lucas, T., van Loo, G., Knipper, J.A., Krieg, T., Haase, I., Brachvogel, B., Hammerschmidt, M., Nagy, A., Ferrara, N., Pasparakis, M., and Eming, S.A. CCR2 recruits an inflammatory macrophage subpopulation critical for angiogenesis in tissue repair. Blood 120, 613, 2012.
137. Spiller, K.L., Anfang, R.R., Spiller, K.J., Ng, J., Nakazawa, K.R., Daulton, J.W., and Vunjak-Novakovic, G. The role of macrophage phenotype in vascularization of tissue engineering scaffolds. Biomaterials 35, 4477, 2014.
138. Sussman, E.M., Halpin, M.C., Muster, J., Moon, R.T., and Ratner, B.D. Porous implants modulate healing and induce shifts in local macrophage polarization in the foreign body reaction. Ann Biomed Eng 42, 1508, 2014.
139. Tous, E., Weber, H.M., Lee, M.H., Koomalsingh, K.J., Shuto, T., Kondo, N., Gorman, J.H., 3rd, Lee, D., Gorman, R.C., and Burdick, J.A. Tunable hydrogel-microsphere composites that modulate local inflammation and collagen bulking. Acta Biomater 8, 3218, 2012.
140. Qi, J.H., Ebrahem, Q., Moore, N., Murphy, G., Claesson-Welsh, L., Bond, M., Baker, A., and Anand-Apte, B. A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2. Nat Med 9, 407, 2003.
141. Rosenberg, G.A. Matrix metalloproteinases and their multiple roles in neurodegenerative diseases. Lancet Neurol 8, 205, 2009.
142. Mohammed, F.F., Smookler, D.S., Taylor, S.E., Fingleton, B., Kassiri, Z., Sanchez, O.H., English, J.L., Matrisian, L.M., Au, B., Yeh, W.C., and Khokha, R. Abnormal TNF activity in Timp3-/-mice leads to chronic hepatic inflammation and failure of liver regeneration. Nat Genet 36, 969, 2004.
143. Saunders, W.B., Bohnsack, B.L., Faske, J.B., Anthis, N.J., Bayless, K.J., Hirschi, K.K., and Davis, G.E. Coregulation of vascular tube stabilization by endothelial cell TIMP-2 and pericyte TIMP-3. J Cell Biol 175, 179, 2006.
144. Jadhav, U., Chigurupati, S., Lakka, S.S., and Mohanam, S. Inhibition of matrix metalloproteinase-9 reduces in vitro invasion and angiogenesis in human microvascular endothelial cells. Int J Oncol 25, 1407, 2004.
145. Ardi, V.C., Kupriyanova, T.A., Deryugina, E.I., and Quigley, J.P. Human neutrophils uniquely release TIMPfree MMP-9 to provide a potent catalytic stimulator of angiogenesis. Proc Natl Acad Sci U S A 104, 20262, 2007.
146. Koh, Y.W., Park, C.S., Yoon, D.H., Suh, C., and Huh, J. CD163 expression was associated with angiogenesis and shortened survival in patients with uniformly treated classical Hodgkin lymphoma. PLoS One 9, e87066, 2014.
147. Wang, F.Q., Chen, G., Zhu, J.Y., Zhang, W., Ren, J.G., Liu, H., Sun, Z.J., Jia, J., and Zhao, Y.F. M2-polarised macrophages in infantile haemangiomas: correlation with promoted angiogenesis. J Clin Pathol 66, 1058, 2013.
148. Zhang, Q., Atsuta, I., Liu, S., Chen, C., Shi, S., Shi, S., and Le, A.D. IL-17-mediated M1/M2 macrophage alteration contributes to pathogenesis of bisphosphonate-related osteonecrosis of the jaws. Clin Cancer Res 19, 3176, 2013.
149. Zaiss, M.M., Kurowska-Stolarska, M., Bohm, C., Gary, R., Scholtysek, C., Stolarski, B., Reilly, J., Kerr, S., Millar, N.L., Kamradt, T., McInnes, I.B., Fallon, P.G., David, J.P., Liew, F.Y., and Schett, G. IL-33 shifts the balance from osteoclast to alternatively activated macrophage differentiation and protects from TNF-alphamediated bone loss. J Immunol 186, 6097, 2011.
150. Seebach, E., Freischmidt, H., Holschbach, J., Fellenberg, J., and Richter, W. Mesenchymal stroma cells trigger early attraction of M1 macrophages and endothelial cells into fibrin hydrogels, stimulating long bone healing without long-term engraftment. Acta Biomater 10, 4730, 2014.
151. Hughes, J.E., Srinivasan, S., Lynch, K.R., Proia, R.L., Ferdek, P., and Hedrick, C.C. Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages. Circ Res 102, 950, 2008.
152. Petrie Aronin, C.E., Shin, S.J., Naden, K.B., Rios, P.D., Jr., Sefcik, L.S., Zawodny, S.R., Bagayoko, N.D., Cui, Q., Khan, Y., and Botchwey, E.A. The enhancement of bone allograft incorporation by the local delivery of the sphingosine 1-phosphate receptor targeted drug FTY720. Biomaterials 31, 6417, 2010.
153. Das, A., Segar, C.E., Hughley, B.B., Bowers, D.T., and Botchwey, E.A. The promotion of mandibular defect healing by the targeting of S1P receptors and the recruitment of alternatively activated macrophages. Biomaterials 34, 9853, 2013.
154. Awojoodu, A.O., Ogle, M.E., Sefcik, L.S., Bowers, D.T., Martin, K., Brayman, K.L., Lynch, K.R., Peirce-Cottler, S.M., and Botchwey, E. Sphingosine 1-phosphate receptor 3 regulates recruitment of anti-inflammatory monocytes to microvessels during implant arteriogenesis. Proc Natl Acad Sci U S A 110, 13785, 2013.
155. Kim, Y.H., Furuya, H., and Tabata, Y. Enhancement of bone regeneration by dual release of a macrophage recruitment agent and platelet-rich plasma from gelatin hydrogels. Biomaterials 35, 214, 2014.
156. Spiller, K.L., Nassiri, S., Witherel, C.E., Anfang, R., Ng, J., Nakazawa, K., Yu, T., and Vunjak Novakovic, G. Sequential delivery of cytokines to facilitate the M1-to-M2 transition of macrophages and enhance vascularization of bone scaffolds. Biomaterials 37, 194, 2015.
157. Mueller, M.B, and Tuan, R.S. Functional characterization of hypertrophy in chondrogenesis of human mesenchymal stem cells. Arthritis Rheum 58, 1377, 2008.
158. Scotti, C., Tonnarelli, B., Papadimitropoulos, A., Scherberich, A., Schaeren, S., Schauerte, A., Lopez-Rios, J., Zeller, R., Barbero, A., and Martin, I. Recapitulation of endochondral bone formation using human adult mesenchymal stem cells as a paradigm for developmental engineering. Proc Natl Acad Sci U S A 107, 7251, 2010.
159. Bahney, C.S., Hu, D.P., Taylor, A.J., Ferro, F., Britz, H.M., Hallgrimsson, B., Johnstone, B., Miclau, T., and Marcucio, R.S. Stem cell-derived endochondral cartilage stimulates bone healing by tissue transformation. J Bone Miner Res 29, 1269, 2014.
160. Scotti, C., Piccinini, E., Takizawa, H., Todorov, A., Bourgine, P., Papadimitropoulos, A., Barbero, A., Manz, M.G., and Martin, I. Engineering of a functional bone organ through endochondral ossification. Proc Natl Acad Sci U S A 110, 3997, 2013.
161. Serafini, M., Sacchetti, B., Pievani, A., Redaelli, D., Remoli, C., Biondi, A., Riminucci, M., and Bianco, P. Establishment of bone marrow and hematopoietic niches in vivo by reversion of chondrocyte differentiation of human bone marrow stromal cells. Stem Cell Res 12, 659, 2014.
162. Zhou, X., von der Mark, K., Henry, S., Norton, W., Adams, H., and de Crombrugghe, B. Chondrocytes transdifferentiate into osteoblasts in endochondral bone during development, postnatal growth and fracture healing in mice. Plos Genet 10, 2014.
163. Harada, N., Watanabe, Y., Sato, K., Abe, S., Yamanaka, K., Sakai, Y., Kaneko, T., and Matsushita, T. Bone regeneration in a massive rat femur defect through endochondral ossification achieved with chondrogenically differentiated MSCs in a degradable scaffold. Biomaterials 35, 7800, 2014.
164. Bourgine, P.E., Scotti, C., Pigeot, S., Tchang, L.A., Todorov, A., and Martin, I. Osteoinductivity of engineered cartilaginous templates devitalized by inducible apoptosis. Proc Natl Acad Sci U S A 111, 17426, 2014.
165. Gawlitta, D., Benders, K.E.M., Visser, J., van der Sar, A.S., Kempen, D.H.R., Theyse, L.F.H., Malda, J., and Dhert, W.J.A. Decellularized cartilage-derived matrix as substrate for endochondral bone regeneration. Tissue Eng Part A 21, 694, 2015.
166. Reinisch, A., Etchart, N., Thomas, D., Hofmann, N.A., Fruehwirth, M., Sinha, S., Chan, C.K., Senarath-Yapa, K., Seo, E.-Y., Wearda, T., Hartwig, U.F., Beham-Schmid, C., Trajanoski, S., Lin, Q., Wagner, W., Dullin, C., Alves, F., Andreeff, M., Weissman, I.L., Longaker, M.T., Schallmoser, K., Majeti, R., and Strunk, D. Epigenetic and in vivo comparison of diverse MSC sources reveals an endochondral signature for human hematopoietic niche formation. Blood 125, 249, 2015.